These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 32406744

  • 1. [Is there life after teduglutide?].
    Martínez Martínez AL, Calles Romero LA, Etxeberría Martín E, Monasterio Jiménez O, Zabalegui Eguinoa A, Paja Fano M, Monzón Mendiolea A, Cadenas González A, Cabriada Nuno JL, Iglesias Hernández NC.
    Nutr Hosp; 2020 Jul 13; 34(3):631-635. PubMed ID: 32406744
    [Abstract] [Full Text] [Related]

  • 2. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Gastroenterology; 2018 Mar 13; 154(4):874-885. PubMed ID: 29174926
    [Abstract] [Full Text] [Related]

  • 3. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.
    Clin Nutr; 2013 Oct 13; 32(5):713-21. PubMed ID: 23587733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ.
    Gut; 2011 Jul 13; 60(7):902-14. PubMed ID: 21317170
    [Abstract] [Full Text] [Related]

  • 6. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S, Maasberg S, Rieger A, Karber M, Blüthner E, Knappe-Drzikova B, Thurmann D, Büttner J, Weylandt KH, Wiedenmann B, Müller VA, Bläker H, Pascher A, Pape UF.
    Clin Nutr; 2019 Aug 13; 38(4):1745-1755. PubMed ID: 30145039
    [Abstract] [Full Text] [Related]

  • 7. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
    Germán-Díaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodríguez A, Galera R, García-Romero R, Romero C, González-Sacristán R, Redecillas-Ferreiro S, Moreno-Villares JM, Ramos-Boluda E.
    Eur J Pediatr; 2024 Aug 13; 183(8):3173-3182. PubMed ID: 38664251
    [Abstract] [Full Text] [Related]

  • 8. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F, Seguy D, Nuzzo A, Chambrier C, Beau P, Poullenot F, Thibault R, Armengol Debeir L, Layec S, Boehm V, Lallemand J, Quilliot D, Schneider SM.
    Clin Nutr; 2020 Sep 13; 39(9):2856-2862. PubMed ID: 31932048
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB.
    Gut; 2005 Sep 13; 54(9):1224-31. PubMed ID: 16099790
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A, To C, Alvarez A, Lara LF.
    JPEN J Parenter Enteral Nutr; 2018 May 13; 42(4):821-825. PubMed ID: 29603279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T, Stoll B, Mecklenburg L, Burrin DG, Vegge A, Qvist N, Eriksen T, Jeppesen PB, Sangild PT.
    J Pediatr Gastroenterol Nutr; 2014 Jun 13; 58(6):694-702. PubMed ID: 24399211
    [Abstract] [Full Text] [Related]

  • 15. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL, Fujioka K, Boullata JI, Iyer K, Lee HM, Ziegler TR.
    Nutr Clin Pract; 2018 Aug 13; 33(4):520-527. PubMed ID: 29761915
    [Abstract] [Full Text] [Related]

  • 16. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
    Micic D, Robinson I, Kidd T, Terreri B, Raphael BP.
    Nutr Clin Pract; 2024 Jun 13; 39(3):634-640. PubMed ID: 38491966
    [Abstract] [Full Text] [Related]

  • 17. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR, Kunecki M, Boullata JI, Fujioka K, Joly F, Gabe S, Pape UF, Schneider SM, Virgili Casas MN, Ziegler TR, Li B, Youssef NN, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2017 Aug 13; 41(6):946-951. PubMed ID: 27875291
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K, Schwartz L, Batisti J, Iyer KR.
    JPEN J Parenter Enteral Nutr; 2018 Jan 13; 42(1):225-230. PubMed ID: 29505151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.